Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Medtronic plc Director's Dealing 2015

Apr 22, 2015

29841_dirs_2015-04-22_047fd197-9d59-4f70-a264-31b097d0c949.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2015-01-26

Reporting Person: Hanson Bryan C (EVP & Group President,Covidien)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-01-26 Ordinary Shares A 83123 Acquired 83123 Direct

Footnotes

F1: This balance was incorrectly reported as 126,953 and has been corrected.

F2: Represents shares of Medtronic plc ("New Medtronic") acquired pursuant to the merger (the "Merger", executed pursuant to the "Transaction Agreement") of a wholly-owned subsidiary of New Medtronic with and into Covidien plc ("Covidien"), with Covidien surviving as a wholly-owned subsidiary of New Medtronic, by means of a "scheme of arrangement", an Irish statutory procedure under the Companies Act of 1963. At the effective time of the Merger, each Covidien ordinary share was cancelled and converted into the right to receive 0.956 ordinary shares of New Medtronic and $35.19. Under the terms of the Transaction Agreement, Covidien shareholders received cash in lieu of fractional shares of New Medtronic.